# Gingivitis: Development and Evaluation of Drugs for Treatment or Prevention - FDA Guidance Document

Source: https://www.globalkeysolutions.net/guidances/guidance-document/gingivitis-development-and-evaluation-of-drugs-for-treatment-or-prevention/bec1ab26-9d0e-468e-ac35-7797add101ae

> FDA guidance document: Gingivitis: Development and Evaluation of Drugs for Treatment or Prevention. Issue date: January 28, 2005. Get complete insights and analysis.

---

## Details

- Title: Gingivitis: Development and Evaluation of Drugs for Treatment or Prevention
- Communication Type: Guidance Document
- Product Type: drugs
- Office Name: Center for Drug Evaluation and Research
- Office URL: /offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
- Issue Date: 2005-01-28
- Last Changed: 2025-02-03

## Related Documents

- [Migraine:  Developing Drugs for Preventive Treatment](https://www.globalkeysolutions.net/guidances/guidance-document/migraine-developing-drugs-for-preventive-treatment/cd739d7c-f8ed-4a37-b16f-d6f3b9550a94)
- [Alcoholism:  Developing Drugs for Treatment](https://www.globalkeysolutions.net/guidances/guidance-document/alcoholism-developing-drugs-for-treatment/5dd607ce-ea00-4415-bc0a-e05b7963322b)
- [Public Availability of Labeling Changes in "Changes Being Effected" Supplements](https://www.globalkeysolutions.net/guidances/guidance-document/public-availability-of-labeling-changes-in-changes-being-effected-supplements/0cd869a7-e345-4545-b817-9cde8e7c7438)